Gilead Sciences

Gilead Sciences, Inc. is a prominent American biopharmaceutical company based in Foster City, California. Founded in 1987 by Michael L. Riordan, Gilead specializes in the research, development, and marketing of antiviral drugs for serious viral diseases, including HIV/AIDS, hepatitis B and C, influenza, and COVID-19. The company went public in 1992 and has since grown to operate in over 20 countries with a large workforce. Gilead offers a diverse range of antiviral medications, such as Viread and Truvada for HIV, ledipasvir/sofosbuvir for hepatitis C, and Tamiflu for influenza. The company has also expanded into cell therapy through its acquisition of Kite Pharma in 2017, focusing on cancer treatment. Gilead is committed to addressing public health challenges, with initiatives like the COMPASS Initiative® aimed at tackling the HIV epidemic in the Southern U.S. and programs that support affected communities.

Research Foster City, United States Founded 1987 ~10,055 employees NASDAQ: GILD

Work at Gilead Sciences in HR or recruiting? Claim this page

Employees
10,055
+0.5% in 3 months
Revenue / employee
$2.9M
Revenue ~$28.7B
Stock
GILD
NASDAQ
12-month attrition
7.9%
Tech: 12.3%
H1B filings, FY2026
137
Sponsors visas
Open jobs
275
Last 30 days

Headcount trend

Gilead Sciences went from 9,780 employees in Jul 2023 to 10,055 in Jun 2025. Last 6 months: 376 people joined, 244 left.

Org structure

Headcount by department

Other6,794
Operations1,336
Engineering681
Sales417
Marketing270
Finance269
HR150
Product64

Executive compensation

Hiring now

See all jobs

Salaries at Gilead Sciences

All salaries

192 salary profiles in the US

Most reported roles

Pay by level, gender and ethnicity · India salaries

H-1B sponsorship

H-1B Sponsorship Moderate
H-1B Filings by Department
Engineering414
Operations151
Executive26
Consulting22
IT14

The department split adds up all the years listed above. FY2026 alone: 137 filings.

Peer reviews

Worked with someone at Gilead Sciences?

Anonymous peer reviews on OffTheRecord

Read or write a review

Similar companies

Gilead Sciences FAQ

How many employees does Gilead Sciences have?

Gilead Sciences has about 10,055 employees, up 0.5% over the last 3 months (as of Jun 2025).

Does Gilead Sciences sponsor H1B visas?

Yes. Gilead Sciences filed 137 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.

What is Gilead Sciences's revenue per employee?

Gilead Sciences makes about $2.86M in revenue per employee, based on $28.73B annual revenue and 10,055 employees.

How much does Gilead Sciences pay?

6figr has 192 salary profiles for Gilead Sciences in the US and 1 in India, with pay broken down by role, level, gender and ethnicity on the Gilead Sciences salaries page. See Gilead Sciences salaries in the US

Is Gilead Sciences a public company?

Yes. Gilead Sciences is publicly traded under the ticker GILD on NASDAQ.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles. Updated 21 Oct 2026.